irbesartan (Q947266)

dyddiad cyhoeddi

17 Tachwedd 2015

adeiledd gemegol

Irbesartan polymorph A.svg
366 × 282; 30 KB

1 ffynhonnell

mewnforiwyd o

Wicipedia Almaeneg

màs

428.23246 uned Dalton

1 ffynhonnell

PubChem ^Saesneg

PubChem CID ^Saesneg

138402-11-6 (Saesneg)

4 Hydref 2016

fformwla gemegol

C₂₅H₂₈N₆O

1 ffynhonnell

PubChem ^Saesneg

PubChem CID ^Saesneg

138402-11-6 (Saesneg)

19 Tachwedd 2016

SMILES

CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5

1 ffynhonnell

PubChem ^Saesneg

PubChem CID ^Saesneg

138402-11-6 (Saesneg)

19 Tachwedd 2016

defined daily dose ^Saesneg

0.15 gram

dull gweini

gweini genau

1 ffynhonnell

https://www.whocc.no/atc_ddd_index/?code=C09CA04

cynhwysyn actif yn

Aprovel ^Saesneg

1 ffynhonnell

EMEA/H/C/000141

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000141/human_med_000649.jsp

22 Mawrth 2017

Irbesartan Bms ^Saesneg

1 ffynhonnell

EMEA/H/C/000786

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000786/human_med_000851.jsp

22 Mawrth 2017

Irbesartan Teva ^Saesneg

1 ffynhonnell

EMEA/H/C/001093

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001093/human_med_000855.jsp

22 Mawrth 2017

Irbesartan Zentiva ^Saesneg

1 ffynhonnell

EMEA/H/C/000785

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000785/human_med_000856.jsp

22 Mawrth 2017

Karvea ^Saesneg

1 ffynhonnell

EMEA/H/C/000142

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000142/human_med_000868.jsp

22 Mawrth 2017

Sabervel ^Saesneg

1 ffynhonnell

EMEA/H/C/002510

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002510/human_med_001556.jsp

22 Mawrth 2017

Avapro ^Saesneg

1 ffynhonnell

RxNorm ^Saesneg

RxNorm ID ^Saesneg

153668

14 Chwefror 2018

World Health Organisation international non-proprietary name ^Saesneg

irbesartan (Saesneg)

1 ffynhonnell

ChEBI ^Saesneg

ChEBI ID ^Saesneg

irbesartan (Saesneg)

4 Hydref 2016

2 ffynonellau

NDF-RT ^Saesneg

13 Rhagfyr 2016

Drug Indications Extracted from FAERS ^Saesneg

2 Hydref 2018

significant drug interaction ^Saesneg

lisinopril dihydrate ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

lisinopril dihydrate ^Saesneg

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

trimethoprim

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

triamteren

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

amilorid

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

eplerenone ^Saesneg

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

spironolacton

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

nabwmeton

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

naprocsen

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

celecocsib

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

dicloffenac

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

pirocsicam

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

melocsicam

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

ffenoproffen

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

fflwrbiproffen

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

ibwproffen

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

indometacin

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

cetoproffen

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

etodolac

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

swlindac

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

parecoxib ^Saesneg

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

tenoxicam ^Saesneg

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

eplerenone ^Saesneg

side effect ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

spironolacton

side effect ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

nabwmeton

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

nabwmeton

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

naprocsen

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

naprocsen

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

celecocsib

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

celecocsib

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

dicloffenac

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

dicloffenac

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

pirocsicam

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

pirocsicam

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

melocsicam

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

melocsicam

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

ffenoproffen

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

ffenoproffen

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

fflwrbiproffen

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

fflwrbiproffen

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

ibwproffen

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

ibwproffen

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

indometacin

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

indometacin

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

cetoproffen

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

cetoproffen

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

etodolac

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

etodolac

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

swlindac

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

swlindac

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

parecoxib ^Saesneg

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

parecoxib ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

tenoxicam ^Saesneg

side effect ^Saesneg

increased systemic arterial blood pressure ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

tenoxicam ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

lisinopril dihydrate ^Saesneg

side effect ^Saesneg

acute kidney injury ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

lisinopril dihydrate ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

lisinopril dihydrate ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

acute kidney injury ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

acute kidney injury ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

acute kidney injury ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

acute kidney injury ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

acute kidney injury ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

acute kidney injury ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

hyperkalemia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

acute kidney injury ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

adweithia'n ffisegol gyda

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

Angiotensin II receptor type 1 ^Saesneg

rôl y pwnc

antagonist ^Saesneg

1 ffynhonnell

17 Awst 2016

Solute carrier family 10 member 1 ^Saesneg

rôl y pwnc

antagonist ^Saesneg

1 ffynhonnell

17 Awst 2016

legal status (medicine) ^Saesneg

boxed warning ^Saesneg

1 ffynhonnell

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

categori beichiogrwydd Awstralia D

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (Saesneg)

categori beichiogrwydd

1 ffynhonnell

mewnforiwyd o

Wicipedia Saesneg

LiverTox likelihood score ^Saesneg

LiverTox toxicity likelihood category C ^Saesneg

1 ffynhonnell

LiverTox ^Saesneg

8 Ebrill 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Irbesartan

last update ^Saesneg

13 Ionawr 2017

rôl y pwnc

angiotensin II receptor antagonist ^Saesneg

1 ffynhonnell

15 Mawrth 2018

antihypertensive drug ^Saesneg

1 ffynhonnell

15 Mawrth 2018

Irbesartan

0 ffynonellau

Identifiers

InChI

InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)

1 ffynhonnell

PubChem ^Saesneg

PubChem CID ^Saesneg

138402-11-6 (Saesneg)

YOSHYTLCDANDAN-UHFFFAOYSA-N

19 Tachwedd 2016

InChIKey ^Saesneg

2 ffynonellau

PubChem ^Saesneg

PubChem CID ^Saesneg

138402-11-6 (Saesneg)

19 Tachwedd 2016

ChEBI release 2020-09-01 ^Saesneg

Rhif Cofrestru CAS

138402-11-6

2 ffynonellau

UNII ^Saesneg

irbesartan (Saesneg)

YOSHYTLCDANDAN-UHFFFAOYSA-N

19 Tachwedd 2016

InChIKey ^Saesneg

CAS Common Chemistry ^Saesneg

10 Ebrill 2021

https://commonchemistry.cas.org/detail?cas_rn=138402-11-6

ChemSpider ID ^Saesneg

3618

1 ffynhonnell

ChemSpider ^Saesneg

ChemSpider ID ^Saesneg

3618

Irbesartan (Saesneg)

19 Tachwedd 2016

PubChem CID ^Saesneg

1 ffynhonnell

PubChem ^Saesneg

PubChem CID ^Saesneg

138402-11-6 (Saesneg)

19 Tachwedd 2016

Reaxys registry number ^Saesneg

6620400

1 ffynhonnell

ChEBI ^Saesneg

ChEBI ID ^Saesneg

irbesartan (Saesneg)

4 Hydref 2016

ChEBI ID ^Saesneg

mapping relation type ^Saesneg

exact match ^Saesneg

1 ffynhonnell

ChEMBL ^Saesneg

ChEMBL ID ^Saesneg

CHEMBL1513

IRBESARTAN (Saesneg)

19 Tachwedd 2016

ChEMBL ID ^Saesneg

CHEMBL1513

1 ffynhonnell

ChEMBL ^Saesneg

ChEMBL ID ^Saesneg

CHEMBL1513

IRBESARTAN (Saesneg)

19 Tachwedd 2016

UniChem compound ID ^Saesneg

209618

1 ffynhonnell

MSBNK-Athens_Univ-AU209402

UniChem ^Saesneg

MassBank accession ID ^Saesneg

SM818701

0 ffynonellau

SM818756

0 ffynonellau

0 ffynonellau

MSBNK-Athens_Univ-AU209403

0 ffynonellau

MSBNK-Athens_Univ-AU209404

0 ffynonellau

MSBNK-Athens_Univ-AU209405

0 ffynonellau

MSBNK-Athens_Univ-AU209407

0 ffynonellau

MSBNK-Athens_Univ-AU209408

0 ffynonellau

MSBNK-Athens_Univ-AU209409

0 ffynonellau

MSBNK-Athens_Univ-AU209410

0 ffynonellau

MSBNK-Athens_Univ-AU209411

0 ffynonellau

MSBNK-Athens_Univ-AU209451

0 ffynonellau

MSBNK-Athens_Univ-AU209452

0 ffynonellau

MSBNK-Athens_Univ-AU209453

0 ffynonellau

MSBNK-Athens_Univ-AU209454

0 ffynonellau

MSBNK-Athens_Univ-AU209455

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

MSBNK-Waters-WA001036

0 ffynonellau

MSBNK-Waters-WA001037

0 ffynonellau

MSBNK-Waters-WA001038

0 ffynonellau

MSBNK-Waters-WA001039

0 ffynonellau

MSBNK-Waters-WA001040

0 ffynonellau

MSBNK-Waters-WA001041

0 ffynonellau

MSBNK-Waters-WA001042

0 ffynonellau

SPLASH ^Saesneg

splash10-0a4i-0190000000-97e745948e54828d3cb9

0 ffynonellau

splash10-0a4i-0190000000-da94b482f79a90e5784c

0 ffynonellau

splash10-0a4i-0590000000-122d562d8d5352dd2a88

0 ffynonellau

splash10-004i-0000900000-b6619e18dca63147588d

0 ffynonellau

splash10-004l-0801900000-b884691a3577ffab749f

0 ffynonellau

splash10-0006-0900000000-130056acf88b6caed131

0 ffynonellau

splash10-0006-0900000000-97919ed4377a869dc8cc

0 ffynonellau

splash10-0006-0900000000-55cf0ae2c686af5c38e3

0 ffynonellau

splash10-0a4i-0290100000-e3c8e0950f0290ccefdc

0 ffynonellau

splash10-004i-0000900000-61da6c552b6d170d8283

0 ffynonellau

splash10-0a4i-0290100000-0e7bf8c50467ae6a7604

0 ffynonellau

splash10-0a4i-0290000000-21c875faccf2cb3a15b3

0 ffynonellau

splash10-0a4i-0490000000-e7c75f4866b7b9f0d0e8

0 ffynonellau

splash10-0a59-1960000000-a6601ea10b0fe87e6c0a

0 ffynonellau

splash10-0a5c-0920000000-d7f5d3920f8586eac33f

0 ffynonellau

splash10-004i-0000900000-57215a52cacf3c9ede5c

0 ffynonellau

splash10-0a4i-0290100000-29a34a51d9b42976905f

0 ffynonellau

splash10-0a4i-0290000000-e6e7f5d1e696ec43651d

0 ffynonellau

splash10-0a4i-1690000000-217de4040066a20fd367

0 ffynonellau

splash10-0a59-1950000000-ac722925e6b2aa2930fb

0 ffynonellau

splash10-0a5c-0930000000-0b8d8a97e3db30de0e21

0 ffynonellau

splash10-0a4i-0290100000-ee3d21bc8110bf939cdd

0 ffynonellau

splash10-0007-0908000000-0c994ee86857e7d63e48

0 ffynonellau

splash10-004i-0000900000-b610a12a9852ff1a11c1

0 ffynonellau

splash10-0006-0900100000-c9024d0b00a0ec781fa2

0 ffynonellau

splash10-0006-0900000000-cb54b7c0917d67313110

0 ffynonellau

splash10-0006-0900000000-4e0d1ebbc0609ecaa59d

0 ffynonellau

splash10-0006-0900000000-ec0fc575bb22a99c258d

0 ffynonellau

splash10-00di-0900000000-f1f0658a24e5097674e0

0 ffynonellau

splash10-004i-0000900000-12da76073bae1768b7e2

0 ffynonellau

splash10-0006-0900000000-cce4e6a8c5bbaa66c902

0 ffynonellau

splash10-0006-0900000000-c7202e4de31fc762cf2d

0 ffynonellau

splash10-0006-0900000000-ad31324f1b1a0e9be0b8

0 ffynonellau

splash10-0006-0900000000-2301c02c521c3dab9c79

0 ffynonellau

splash10-00di-0900000000-8b6e9e772c5af1365e87

0 ffynonellau

splash10-0007-0908000000-97706153fba817a654e4

0 ffynonellau

splash10-0a59-2791700000-a5bc1c8b020f7731fb1e

0 ffynonellau

splash10-0a6r-0490500000-2693358cc0b819b773a5

0 ffynonellau

splash10-002f-0900400000-f9f11306595c7a9de207

0 ffynonellau

dynodwr HSDB

8215

1 ffynhonnell

Hazardous Substances Data Bank ^Saesneg

28 Hydref 2019

Irbesartan (Saesneg)

10 Mai 2021

DSSTox substance ID ^Saesneg

DTXSID0023169

1 ffynhonnell

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Saesneg

DSSTOX compound identifier ^Saesneg

DTXCID903169

0 ffynonellau

LiverTox ID ^Saesneg

Irbesartan

0 ffynonellau

NSC number ^Saesneg

758696

0 ffynonellau

EC number ^Saesneg

604-078-2

1 ffynhonnell

ECHA Substance Infocard database ^Saesneg

ECHA Substance Infocard ID ^Saesneg

100.119.966

27 Rhagfyr 2018

2-butyl-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one (Saesneg)

dyfyniad

CAS no.: 138402-11-6 (Saesneg)

ECHA Substance Infocard ID ^Saesneg

100.119.966

1 ffynhonnell

ECHA Substance Infocard database ^Saesneg

ECHA Substance Infocard ID ^Saesneg

100.119.966

27 Rhagfyr 2018

2-butyl-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one (Saesneg)

dyfyniad

CAS no.: 138402-11-6 (Saesneg)

Cod yr ATC

C09CA04

1 ffynhonnell

DrugBank ^Saesneg

Irbesartan (Saesneg)

dyddiad cyhoeddi

17 Tachwedd 2015

1 ffynhonnell

irbesartan (Saesneg)

19 Tachwedd 2016

1 ffynhonnell

D02.455.426.559.389.185.413

5 Chwefror 2021

Irbesartan

0 ffynonellau

Cod MeSH

0 ffynonellau

D02.455.426.779.431

0 ffynonellau

D03.383.129.617.351

0 ffynonellau

D04.711.431

0 ffynonellau

RxNorm ID ^Saesneg

83818

1 ffynhonnell

UNII ^Saesneg

irbesartan (Saesneg)

19 Tachwedd 2016

1 ffynhonnell

DrugBank ^Saesneg

Irbesartan (Saesneg)

19 Tachwedd 2016

UNII ^Saesneg

1 ffynhonnell

UNII ^Saesneg

irbesartan (Saesneg)

19 Tachwedd 2016

MedlinePlus drug identifier ^Saesneg

a698009

0 ffynonellau

PatientsLikeMe treatment ID ^Saesneg

0 ffynonellau

1 ffynhonnell

UNII ^Saesneg

irbesartan (Saesneg)

19 Tachwedd 2016

Probes And Drugs ID ^Saesneg

PD001208

0 ffynonellau

DrugCentral ID ^Saesneg

1 ffynhonnell

UniChem ^Saesneg

1 ffynhonnell

ChEBI ^Saesneg

ChEBI ID ^Saesneg

irbesartan (Saesneg)

4 Hydref 2016

1 ffynhonnell

ChEBI ^Saesneg

ChEBI ID ^Saesneg

irbesartan (Saesneg)

dynodwr Microsoft Academic

4 Hydref 2016

DeCS ID ^Saesneg

0 ffynonellau

1 ffynhonnell

Freebase Data Dumps ^Saesneg

dyddiad cyhoeddi

28 Hydref 2013

2780259554

0 ffynonellau

OpenAlex ID ^Saesneg

1 ffynhonnell

OpenAlex ^Saesneg

26 Ionawr 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

UMLS CUI ^Saesneg

C0288171

1 ffynhonnell

UNII ^Saesneg

irbesartan (Saesneg)